Loading
Depression, Anxiety / Breath Awareness using pyramid · Interventional Study
ClinicalTrials.gov · September 10, 2026
Early or partial results. Treat as a signal, not a conclusion.
This is a completed pilot study registration examining whether breath awareness practice using pyramid geometry can reduce anxiety and depression symptoms in people with type 2 diabetes. No outcome data are posted in this registry record, and the design (single-arm, small sample) and novel intervention (pyramid structure) position this as exploratory work requiring larger, controlled trials before clinical interpretation.
Interventional, Randomized, Parallel, Single masking, Supportive Care purpose. Depression, Anxiety; age from 30 Years; to 80 Years. Intervention: intervention. Compared with: control — No Intervention. n = 20. 1 site: Kuwait.
This is a completed pilot study registration examining whether breath awareness practice using pyramid geometry can reduce anxiety and depression symptoms in people with type 2 diabetes. No outcome data are posted in this registry record, and the design (single-arm, small sample) and novel intervention (pyramid structure) position this as exploratory work requiring larger, controlled trials before clinical interpretation.
This registry record reports no outcome results; efficacy and safety cannot be assessed.
No results are available from this registry record. Once outcome data are published, clinicians should await results and formal peer-reviewed reporting before considering adoption, given the pilot nature and lack of a control group.
Pilot study with completed enrollment of 20 participants examining a novel behavioral intervention (breath awareness using pyramid geometry) for anxiety and depression in type 2 diabetes; no results are reported in this registry record.
As stated by the source record.
Quoted from the source exactly as published.
No results are available from this registry record. Once outcome data are published, clinicians should await results and formal peer-reviewed reporting before considering adoption, given the pilot nature and lack of a control group.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no key findings. That is a gap in the analysis, not a judgement about the study.
Registry record from ClinicalTrials.gov (NCT06632782). This is a study registration, not published results. Lead sponsor: Dasman Diabetes Institute. Recruitment status: COMPLETED. Phase: NA. Study type: INTERVENTIONAL. Enrollment: 20 participants (ACTUAL). Conditions: Depression, Anxiety. Interventions: BEHAVIORAL: Breath Awareness using pyramid. Primary outcome measures: Change in Hospital Anxiety and depression score(HADS) , 6 weeks; Change in Patient Health Questionnaire PHQ-9 score , 6 weeks; Change in Pitssburgh Sleep Quality Index PSQI score , 6 weeks; Change inMindful Attention Awareness Scale (MAAS) , 6 weeks. Brief summary: Diabetes mellitus is rampant in the Middle East. It is a psychologically and behaviorally demanding disease; psychosocial factors are relevant to nearly all aspects of its management. Moreover, depression and diabetes are bidirectionally connected. Those with depression are at risk of developing diabetes and those with comorbid diabetes are at risk of developing depressive symptoms. Research findings have demonstrated that depression and anxiety are more common in patients with diabetes than in the general population, atleast 15 % have clinical depression. In addition, the recent COVID- 19 pandemic has fueled the burden by increasing fear, anxiety, and depression among people with T2DM due to susceptibility to long-term complications. In Kuwait, a recent survey found the prevalence of depression to be 29% and diabetes distress to be 14%. Thus, there is a dire need to address this challenging problem. In the recent past, mindfulness-based intervention such as Mindfulness-based stress reduction (MBSR), Mindfulness-based cognitive therapy (MBCT,) and yoga have emerged as unique tools for reducing a wide range of psychological disorders. These tools positively impact hormone regulation and have a beneficial effect on cognitive function and increased parasympathetic activity. The positive impact of mindfulness is assumed to be amplified if a pyramid structure with geometry similar to the pyramid of Giza is used for practice. Not much human research has been performed to demonstrate that pyramid energy along with mindfulness can be a tool to combat psychological disorders. However, few studies on animal models provided evidence of the potential beneficial effect of pyramid structure in reducing stress. Previous pilot study conducted using only yoga as an intervention indicated significant improvement in anxiety, depression, and quality of life in people with T2DM. However, there was no change in participants' glycemic control. In this pilot study, investigator will assess whether pyramid breath awareness can alleviate symptoms of depression and anxiety in people with T2DM.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.